Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Dec;64(12):4883–4890. doi: 10.1128/iai.64.12.4883-4890.1996

Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy.

A M van Furth 1, J J Roord 1, R van Furth 1
PMCID: PMC174464  PMID: 8945522

Full Text

The Full Text of this article is available as a PDF (216.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson P. B., Perry V. H., Gordon S. Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J Exp Med. 1992 Jul 1;176(1):255–259. doi: 10.1084/jem.176.1.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arditi M., Ables L., Yogev R. Cerebrospinal fluid endotoxin levels in children with H. influenzae meningitis before and after administration of intravenous ceftriaxone. J Infect Dis. 1989 Dec;160(6):1005–1011. doi: 10.1093/infdis/160.6.1005. [DOI] [PubMed] [Google Scholar]
  3. Arditi M., Kabat W., Yogev R. Antibiotic-induced bacterial killing stimulates tumor necrosis factor-alpha release in whole blood. J Infect Dis. 1993 Jan;167(1):240–244. doi: 10.1093/infdis/167.1.240. [DOI] [PubMed] [Google Scholar]
  4. Arditi M., Manogue K. R., Caplan M., Yogev R. Cerebrospinal fluid cachectin/tumor necrosis factor-alpha and platelet-activating factor concentrations and severity of bacterial meningitis in children. J Infect Dis. 1990 Jul;162(1):139–147. doi: 10.1093/infdis/162.1.139. [DOI] [PubMed] [Google Scholar]
  5. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. Adv Immunol. 1994;55:97–179. [PubMed] [Google Scholar]
  6. Baggiolini M., Walz A., Kunkel S. L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest. 1989 Oct;84(4):1045–1049. doi: 10.1172/JCI114265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Barnes P. J., Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. Am Rev Respir Dis. 1993 Oct;148(4 Pt 2):S1–26. doi: 10.1164/ajrccm/148.4_Pt_2.S1. [DOI] [PubMed] [Google Scholar]
  8. Beekhuizen H., Corsèl-Van Tilburg A. J., Blokland I., Van Furth R. Characterization of the adherence of human monocytes to cytokine-stimulated human macrovascular endothelial cells. Immunology. 1991 Dec;74(4):661–669. [PMC free article] [PubMed] [Google Scholar]
  9. Belsey M. A., Hoffpauir C. W., Smith M. H. Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results. Pediatrics. 1969 Oct;44(4):503–513. [PubMed] [Google Scholar]
  10. Bessler H., Gilgal R., Djaldetti M., Zahavi I. Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells. J Leukoc Biol. 1986 Dec;40(6):747–754. doi: 10.1002/jlb.40.6.747. [DOI] [PubMed] [Google Scholar]
  11. Beutler B., Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med. 1987 Feb 12;316(7):379–385. doi: 10.1056/NEJM198702123160705. [DOI] [PubMed] [Google Scholar]
  12. Bruyn G. A., Kremer H. P., de Marie S., Padberg G. W., Hermans J., van Furth R. Clinical evaluation of pneumococcal meningitis in adults over a twelve-year period. Eur J Clin Microbiol Infect Dis. 1989 Aug;8(8):695–700. doi: 10.1007/BF01963754. [DOI] [PubMed] [Google Scholar]
  13. Burroughs M., Cabellos C., Prasad S., Tuomanen E. Bacterial components and the pathophysiology of injury to the blood-brain barrier: does cell wall add to the effects of endotoxin in gram-negative meningitis? J Infect Dis. 1992 Jun;165 (Suppl 1):S82–S85. doi: 10.1093/infdis/165-supplement_1-s82. [DOI] [PubMed] [Google Scholar]
  14. Burroughs M., Prasad S., Cabellos C., Mendelman P. M., Tuomanen E. The biologic activities of peptidoglycan in experimental Haemophilus influenzae meningitis. J Infect Dis. 1993 Feb;167(2):464–468. doi: 10.1093/infdis/167.2.464. [DOI] [PubMed] [Google Scholar]
  15. Bursten S., Weeks R., West J., Le T., Wilson T., Porubek D., Bianco J. A., Singer J. W., Rice G. C. Potential role for phosphatidic acid in mediating the inflammatory responses to TNF alpha and IL-1 beta. Circ Shock. 1994 Sep;44(1):14–29. [PubMed] [Google Scholar]
  16. Chantry D., Turner M., Abney E., Feldmann M. Modulation of cytokine production by transforming growth factor-beta. J Immunol. 1989 Jun 15;142(12):4295–4300. [PubMed] [Google Scholar]
  17. Chao C. C., Hu S., Close K., Choi C. S., Molitor T. W., Novick W. J., Peterson P. K. Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. J Infect Dis. 1992 Oct;166(4):847–853. doi: 10.1093/infdis/166.4.847. [DOI] [PubMed] [Google Scholar]
  18. Dawson T. M., Dawson V. L., Snyder S. H. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol. 1992 Sep;32(3):297–311. doi: 10.1002/ana.410320302. [DOI] [PubMed] [Google Scholar]
  19. DeLemos R. A., Haggerty R. J. Corticosteroids as an adjunct to treatment in bacterial meningitis. A controlled clinical trial. Pediatrics. 1969 Jul;44(1):30–34. [PubMed] [Google Scholar]
  20. Dinarello C. A. Biologic basis for interleukin-1 in disease. Blood. 1996 Mar 15;87(6):2095–2147. [PubMed] [Google Scholar]
  21. Dinarello C. A. Biology of interleukin 1. FASEB J. 1988 Feb;2(2):108–115. [PubMed] [Google Scholar]
  22. Ding A., Nathan C. F., Graycar J., Derynck R., Stuehr D. J., Srimal S. Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J Immunol. 1990 Aug 1;145(3):940–944. [PubMed] [Google Scholar]
  23. Dulkerian S. J., Kilpatrick L., Costarino A. T., Jr, McCawley L., Fein J., Corcoran L., Zirin S., Harris M. C. Cytokine elevations in infants with bacterial and aseptic meningitis. J Pediatr. 1995 Jun;126(6):872–876. doi: 10.1016/s0022-3476(95)70199-0. [DOI] [PubMed] [Google Scholar]
  24. Endres S., Fülle H. J., Sinha B., Stoll D., Dinarello C. A., Gerzer R., Weber P. C. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells. Immunology. 1991 Jan;72(1):56–60. [PMC free article] [PubMed] [Google Scholar]
  25. Endres S. Messengers and mediators: interactions among lipids, eicosanoids, and cytokines. Am J Clin Nutr. 1993 May;57(5 Suppl):798S–800S. doi: 10.1093/ajcn/57.5.798S. [DOI] [PubMed] [Google Scholar]
  26. Frei K., Nadal D., Pfister H. W., Fontana A. Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10. J Exp Med. 1993 Oct 1;178(4):1255–1261. doi: 10.1084/jem.178.4.1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Friedland I. R., Jafari H., Ehrett S., Rinderknecht S., Paris M., Coulthard M., Saxen H., Olsen K., McCracken G. H., Jr Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis. J Infect Dis. 1993 Sep;168(3):657–662. doi: 10.1093/infdis/168.3.657. [DOI] [PubMed] [Google Scholar]
  28. Friedland I. R., Paris M. M., Hickey S., Shelton S., Olsen K., Paton J. C., McCracken G. H. The limited role of pneumolysin in the pathogenesis of pneumococcal meningitis. J Infect Dis. 1995 Sep;172(3):805–809. doi: 10.1093/infdis/172.3.805. [DOI] [PubMed] [Google Scholar]
  29. Girgis N. I., Farid Z., Mikhail I. A., Farrag I., Sultan Y., Kilpatrick M. E. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J. 1989 Dec;8(12):848–851. doi: 10.1097/00006454-198912000-00004. [DOI] [PubMed] [Google Scholar]
  30. Glimåker M., Kragsbjerg P., Forsgren M., Olcén P. Tumor necrosis factor-alpha (TNF alpha) in cerebrospinal fluid from patients with meningitis of different etiologies: high levels of TNF alpha indicate bacterial meningitis. J Infect Dis. 1993 Apr;167(4):882–889. doi: 10.1093/infdis/167.4.882. [DOI] [PubMed] [Google Scholar]
  31. Guerra-Romero L., Tureen J. H., Täuber M. G. Pathogenesis of central nervous system injury in bacterial meningitis. Antibiot Chemother (1971) 1992;45:18–29. doi: 10.1159/000420998. [DOI] [PubMed] [Google Scholar]
  32. Gérard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P., Delvaux A., Fiers W., Goldman M., Velu T. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med. 1993 Feb 1;177(2):547–550. doi: 10.1084/jem.177.2.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Halstensen A., Ceska M., Brandtzaeg P., Redl H., Naess A., Waage A. Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J Infect Dis. 1993 Feb;167(2):471–475. doi: 10.1093/infdis/167.2.471. [DOI] [PubMed] [Google Scholar]
  34. Han J., Thompson P., Beutler B. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med. 1990 Jul 1;172(1):391–394. doi: 10.1084/jem.172.1.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Helfgott D. C., Tatter S. B., Santhanam U., Clarick R. H., Bhardwaj N., May L. T., Sehgal P. B. Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol. 1989 Feb 1;142(3):948–953. [PubMed] [Google Scholar]
  36. Henderson B., Wilson M. Cytokine induction by bacteria: beyond lipopolysaccharide. Cytokine. 1996 Apr;8(4):269–282. doi: 10.1006/cyto.1996.0036. [DOI] [PubMed] [Google Scholar]
  37. Heumann D., Barras C., Severin A., Glauser M. P., Tomasz A. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun. 1994 Jul;62(7):2715–2721. doi: 10.1128/iai.62.7.2715-2721.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Hu S., Martella A., Anderson W. R., Chao C. C. Role of cytokines in lipopolysaccharide-induced functional and structural abnormalities of astrocytes. Glia. 1994 Mar;10(3):227–234. doi: 10.1002/glia.440100309. [DOI] [PubMed] [Google Scholar]
  39. Huber A. R., Kunkel S. L., Todd R. F., 3rd, Weiss S. J. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science. 1991 Oct 4;254(5028):99–102. doi: 10.1126/science.1718038. [DOI] [PubMed] [Google Scholar]
  40. Ikejima T., Okusawa S., Ghezzi P., van der Meer J. W., Dinarello C. A. Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J Infect Dis. 1990 Jul;162(1):215–223. doi: 10.1093/infdis/162.1.215. [DOI] [PubMed] [Google Scholar]
  41. Kadurugamuwa J. L., Hengstler B., Zak O. Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents. J Infect Dis. 1989 Jan;159(1):26–34. doi: 10.1093/infdis/159.1.26. [DOI] [PubMed] [Google Scholar]
  42. Kanra G. Y., Ozen H., Seçmeer G., Ceyhan M., Ecevit Z., Belgin E. Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr Infect Dis J. 1995 Jun;14(6):490–494. doi: 10.1097/00006454-199506000-00005. [DOI] [PubMed] [Google Scholar]
  43. Kasama T., Strieter R. M., Lukacs N. W., Burdick M. D., Kunkel S. L. Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol. 1994 Apr 1;152(7):3559–3569. [PubMed] [Google Scholar]
  44. Kern J. A., Lamb R. J., Reed J. C., Daniele R. P., Nowell P. C. Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J Clin Invest. 1988 Jan;81(1):237–244. doi: 10.1172/JCI113301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Kilbourn R. G., Belloni P. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst. 1990 May 2;82(9):772–776. doi: 10.1093/jnci/82.9.772. [DOI] [PubMed] [Google Scholar]
  46. Kilpi T., Peltola H., Jauhiainen T., Kallio M. J. Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatr Infect Dis J. 1995 Apr;14(4):270–278. doi: 10.1097/00006454-199504000-00005. [DOI] [PubMed] [Google Scholar]
  47. Kornelisse R. F., Savelkoul H. F., Mulder P. H., Suur M. H., van der Straaten P. J., van der Heijden A. J., Sukhai R. N., Hählen K., Neijens H. J., de Groot R. Interleukin-10 and soluble tumor necrosis factor receptors in cerebrospinal fluid of children with bacterial meningitis. J Infect Dis. 1996 Jun;173(6):1498–1502. doi: 10.1093/infdis/173.6.1498. [DOI] [PubMed] [Google Scholar]
  48. Kurose I., Kubes P., Wolf R., Anderson D. C., Paulson J., Miyasaka M., Granger D. N. Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ Res. 1993 Jul;73(1):164–171. doi: 10.1161/01.res.73.1.164. [DOI] [PubMed] [Google Scholar]
  49. Lamas S., Michel T., Brenner B. M., Marsden P. A. Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-alpha. Am J Physiol. 1991 Oct;261(4 Pt 1):C634–C641. doi: 10.1152/ajpcell.1991.261.4.C634. [DOI] [PubMed] [Google Scholar]
  50. Lebel M. H., Freij B. J., Syrogiannopoulos G. A., Chrane D. F., Hoyt M. J., Stewart S. M., Kennard B. D., Olsen K. D., McCracken G. H., Jr Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med. 1988 Oct 13;319(15):964–971. doi: 10.1056/NEJM198810133191502. [DOI] [PubMed] [Google Scholar]
  51. Lebel M. H., Hoyt M. J., Waagner D. C., Rollins N. K., Finitzo T., McCracken G. H., Jr Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. Am J Dis Child. 1989 Mar;143(3):301–306. doi: 10.1001/archpedi.1989.02150150055017. [DOI] [PubMed] [Google Scholar]
  52. Lee S. C., Dickson D. W., Brosnan C. F., Casadevall A. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J Exp Med. 1994 Jul 1;180(1):365–369. doi: 10.1084/jem.180.1.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Lehmann A. K., Halstensen A., Sørnes S., Røkke O., Waage A. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect Immun. 1995 Jun;63(6):2109–2112. doi: 10.1128/iai.63.6.2109-2112.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Leist T. P., Frei K., Kam-Hansen S., Zinkernagel R. M., Fontana A. Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients. J Exp Med. 1988 May 1;167(5):1743–1748. doi: 10.1084/jem.167.5.1743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Lesse A. J., Moxon E. R., Zwahlen A., Scheld W. M. Role of cerebrospinal fluid pleocytosis and Haemophilus influenzae type b capsule on blood brain barrier permeability during experimental meningitis in the rat. J Clin Invest. 1988 Jul;82(1):102–109. doi: 10.1172/JCI113556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Lorenzl S., Koedel U., Dirnagl U., Ruckdeschel G., Pfister H. W. Imaging of leukocyte-endothelium interaction using in vivo confocal laser scanning microscopy during the early phase of experimental pneumococcal meningitis. J Infect Dis. 1993 Oct;168(4):927–933. doi: 10.1093/infdis/168.4.927. [DOI] [PubMed] [Google Scholar]
  57. López-Cortés L. F., Cruz-Ruiz M., Gómez-Mateos J., Jiménez-Hernández D., Palomino J., Jiménez E. Measurement of levels of tumor necrosis factor-alpha and interleukin-1 beta in the CSF of patients with meningitis of different etiologies: utility in the differential diagnosis. Clin Infect Dis. 1993 Apr;16(4):534–539. doi: 10.1093/clind/16.4.534. [DOI] [PubMed] [Google Scholar]
  58. López-Cortés L. F., Cruz-Ruiz M., Gómez-Mateos J., Viciana-Fernandez P., Martinez-Marcos F. J., Pachón J. Interleukin-8 in cerebrospinal fluid from patients with meningitis of different etiologies: its possible role as neutrophil chemotactic factor. J Infect Dis. 1995 Aug;172(2):581–584. doi: 10.1093/infdis/172.2.581. [DOI] [PubMed] [Google Scholar]
  59. Marchant A., Bruyns C., Vandenabeele P., Abramowicz D., Gérard C., Delvaux A., Ghezzi P., Velu T., Goldman M. The protective role of interleukin-10 in endotoxin shock. Prog Clin Biol Res. 1994;388:417–423. [PubMed] [Google Scholar]
  60. Marchant A., Bruyns C., Vandenabeele P., Ducarme M., Gérard C., Delvaux A., De Groote D., Abramowicz D., Velu T., Goldman M. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol. 1994 May;24(5):1167–1171. doi: 10.1002/eji.1830240524. [DOI] [PubMed] [Google Scholar]
  61. Marchant A., Devière J., Byl B., De Groote D., Vincent J. L., Goldman M. Interleukin-10 production during septicaemia. Lancet. 1994 Mar 19;343(8899):707–708. doi: 10.1016/s0140-6736(94)91584-9. [DOI] [PubMed] [Google Scholar]
  62. Martich G. D., Danner R. L., Ceska M., Suffredini A. F. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J Exp Med. 1991 Apr 1;173(4):1021–1024. doi: 10.1084/jem.173.4.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Mastroianni C. M., Paoletti F., Rivosecchi R. M., Lancella L., Ticca F., Vullo V., Delia S. Cerebrospinal fluid interleukin 8 in children with purulent bacterial and tuberculous meningitis. Pediatr Infect Dis J. 1994 Nov;13(11):1008–1010. [PubMed] [Google Scholar]
  64. McCracken G. H., Jr, Mustafa M. M., Ramilo O., Olsen K. D., Risser R. C. Cerebrospinal fluid interleukin 1-beta and tumor necrosis factor concentrations and outcome from neonatal gram-negative enteric bacillary meningitis. Pediatr Infect Dis J. 1989 Mar;8(3):155–159. [PubMed] [Google Scholar]
  65. Mertsola J., Kennedy W. A., Waagner D., Sáez-Llorens X., Olsen K., Hansen E. J., McCracken G. H., Jr Endotoxin concentrations in cerebrospinal fluid correlate with clinical severity and neurologic outcome of Haemophilus influenzae type B meningitis. Am J Dis Child. 1991 Oct;145(10):1099–1103. doi: 10.1001/archpedi.1991.02160100031019. [DOI] [PubMed] [Google Scholar]
  66. Mertsola J., Ramilo O., Mustafa M. M., Sáez-Llorens X., Hansen E. J., McCracken G. H., Jr Release of endotoxin after antibiotic treatment of Gram-negative bacterial meningitis. Pediatr Infect Dis J. 1989 Dec;8(12):904–906. doi: 10.1097/00006454-198912000-00036. [DOI] [PubMed] [Google Scholar]
  67. Mizuno T., Sawada M., Marunouchi T., Suzumura A. Production of interleukin-10 by mouse glial cells in culture. Biochem Biophys Res Commun. 1994 Dec 30;205(3):1907–1915. doi: 10.1006/bbrc.1994.2893. [DOI] [PubMed] [Google Scholar]
  68. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  69. Moore K. W., O'Garra A., de Waal Malefyt R., Vieira P., Mosmann T. R. Interleukin-10. Annu Rev Immunol. 1993;11:165–190. doi: 10.1146/annurev.iy.11.040193.001121. [DOI] [PubMed] [Google Scholar]
  70. Musso T., Espinoza-Delgado I., Pulkki K., Gusella G. L., Longo D. L., Varesio L. Transforming growth factor beta downregulates interleukin-1 (IL-1)-induced IL-6 production by human monocytes. Blood. 1990 Dec 15;76(12):2466–2469. [PubMed] [Google Scholar]
  71. Mustafa M. M., Lebel M. H., Ramilo O., Olsen K. D., Reisch J. S., Beutler B., McCracken G. H., Jr Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr. 1989 Aug;115(2):208–213. doi: 10.1016/s0022-3476(89)80067-8. [DOI] [PubMed] [Google Scholar]
  72. Mustafa M. M., Mertsola J., Ramilo O., Sáez-Llorens X., Risser R. C., McCracken G. H., Jr Increased endotoxin and interleukin-1 beta concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapy. J Infect Dis. 1989 Nov;160(5):891–895. doi: 10.1093/infdis/160.5.891. [DOI] [PubMed] [Google Scholar]
  73. Mustafa M. M., Ramilo O., Mertsola J., Risser R. C., Beutler B., Hansen E. J., McCracken G. H., Jr Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis. J Infect Dis. 1989 Nov;160(5):818–825. doi: 10.1093/infdis/160.5.818. [DOI] [PubMed] [Google Scholar]
  74. Mustafa M. M., Ramilo O., Olsen K. D., Franklin P. S., Hansen E. J., Beutler B., McCracken G. H., Jr Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis. J Clin Invest. 1989 Oct;84(4):1253–1259. doi: 10.1172/JCI114292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Mustafa M. M., Ramilo O., Sáez-Llorens X., Mertsola J., Magness R. R., McCracken G. H., Jr Prostaglandins E2 and I2, interleukin 1-beta, and tumor necrosis factor in cerebrospinal fluid in infants and children with bacterial meningitis. Pediatr Infect Dis J. 1989 Dec;8(12):921–922. doi: 10.1097/00006454-198912000-00045. [DOI] [PubMed] [Google Scholar]
  76. Mustafa M. M., Ramilo O., Sáez-Llorens X., Mertsola J., McCracken G. H., Jr Role of tumor necrosis factor alpha (cachectin) in experimental and clinical bacterial meningitis. Pediatr Infect Dis J. 1989 Dec;8(12):907–908. doi: 10.1097/00006454-198912000-00037. [DOI] [PubMed] [Google Scholar]
  77. Mustafa M. M., Ramilo O., Sáez-Llorens X., Olsen K. D., Magness R. R., McCracken G. H., Jr Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients. Am J Dis Child. 1990 Aug;144(8):883–887. doi: 10.1001/archpedi.1990.02150320047024. [DOI] [PubMed] [Google Scholar]
  78. Nadal D., Leppert D., Frei K., Gallo P., Lamche H., Fontana A. Tumour necrosis factor-alpha in infectious meningitis. Arch Dis Child. 1989 Sep;64(9):1274–1279. doi: 10.1136/adc.64.9.1274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Neuner P., Klosner G., Schauer E., Pourmojib M., Macheiner W., Grünwald C., Knobler R., Schwarz A., Luger T. A., Schwarz T. Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. Immunology. 1994 Oct;83(2):262–267. [PMC free article] [PubMed] [Google Scholar]
  80. Niu X. F., Smith C. W., Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res. 1994 Jun;74(6):1133–1140. doi: 10.1161/01.res.74.6.1133. [DOI] [PubMed] [Google Scholar]
  81. Nowicki J. P., Duval D., Poignet H., Scatton B. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur J Pharmacol. 1991 Nov 12;204(3):339–340. doi: 10.1016/0014-2999(91)90862-k. [DOI] [PubMed] [Google Scholar]
  82. Odio C. M., Faingezicht I., Paris M., Nassar M., Baltodano A., Rogers J., Sáez-Llorens X., Olsen K. D., McCracken G. H., Jr The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med. 1991 May 30;324(22):1525–1531. doi: 10.1056/NEJM199105303242201. [DOI] [PubMed] [Google Scholar]
  83. Ohga S., Aoki T., Okada K., Akeda H., Fujioka K., Ohshima A., Mori T., Minamishima I., Ueda K. Cerebrospinal fluid concentrations of interleukin-1 beta, tumour necrosis factor-alpha, and interferon gamma in bacterial meningitis. Arch Dis Child. 1994 Feb;70(2):123–125. doi: 10.1136/adc.70.2.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Ossege L. M., Voss B., Wiethege T., Sindern E., Malin J. P. Detection of transforming growth factor beta 1 mRNA in cerebrospinal fluid cells of patients with meningitis by non-radioactive in situ hybridization. J Neurol. 1994 Dec;242(1):14–19. doi: 10.1007/BF00920569. [DOI] [PubMed] [Google Scholar]
  85. París M. M., Friedland I. R., Ehrett S., Hickey S. M., Olsen K. D., Hansen E., Thonar E. J., McCracken G. H., Jr Effect of interleukin-1 receptor antagonist and soluble tumor necrosis factor receptor in animal models of infection. J Infect Dis. 1995 Jan;171(1):161–169. doi: 10.1093/infdis/171.1.161. [DOI] [PubMed] [Google Scholar]
  86. Patrick D., Betts J., Frey E. A., Prameya R., Dorovini-Zis K., Finlay B. B. Haemophilus influenzae lipopolysaccharide disrupts confluent monolayers of bovine brain endothelial cells via a serum-dependent cytotoxic pathway. J Infect Dis. 1992 May;165(5):865–872. doi: 10.1093/infdis/165.5.865. [DOI] [PubMed] [Google Scholar]
  87. Peltola H., Kilpi T., Anttila M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet. 1992 Sep 5;340(8819):592–594. doi: 10.1016/0140-6736(92)92117-x. [DOI] [PubMed] [Google Scholar]
  88. Pfister H. W., Fontana A., Täuber M. G., Tomasz A., Scheld W. M. Mechanisms of brain injury in bacterial meningitis: workshop summary. Clin Infect Dis. 1994 Sep;19(3):463–479. doi: 10.1093/clinids/19.3.463. [DOI] [PubMed] [Google Scholar]
  89. Pfister H. W., Frei K., Ottnad B., Koedel U., Tomasz A., Fontana A. Transforming growth factor beta 2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor alpha-independent early phase of experimental pneumococcal meningitis. J Exp Med. 1992 Jul 1;176(1):265–268. doi: 10.1084/jem.176.1.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Pomeroy S. L., Holmes S. J., Dodge P. R., Feigin R. D. Seizures and other neurologic sequelae of bacterial meningitis in children. N Engl J Med. 1990 Dec 13;323(24):1651–1657. doi: 10.1056/NEJM199012133232402. [DOI] [PubMed] [Google Scholar]
  91. Prasadarao N. V., Wass C. A., Kim K. S. Endothelial cell GlcNAc beta 1-4GlcNAc epitopes for outer membrane protein A enhance traversal of Escherichia coli across the blood-brain barrier. Infect Immun. 1996 Jan;64(1):154–160. doi: 10.1128/iai.64.1.154-160.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Prasadarao N. V., Wass C. A., Weiser J. N., Stins M. F., Huang S. H., Kim K. S. Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells. Infect Immun. 1996 Jan;64(1):146–153. doi: 10.1128/iai.64.1.146-153.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Quagliarello V. J., Scheld W. M. New perspectives on bacterial meningitis. Clin Infect Dis. 1993 Oct;17(4):603–610. doi: 10.1093/clinids/17.4.603. [DOI] [PubMed] [Google Scholar]
  94. Quagliarello V. J., Wispelwey B., Long W. J., Jr, Scheld W. M. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest. 1991 Apr;87(4):1360–1366. doi: 10.1172/JCI115140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Ramilo O., Mustafa M. M., Porter J., Sáez-Llorens X., Mertsola J., Olsen K. D., Luby J. P., Beutler B., McCracken G. H., Jr Detection of interleukin 1 beta but not tumor necrosis factor-alpha in cerebrospinal fluid of children with aseptic meningitis. Am J Dis Child. 1990 Mar;144(3):349–352. doi: 10.1001/archpedi.1990.02150270099034. [DOI] [PubMed] [Google Scholar]
  96. Ramilo O., Mustafa M. M., Sáez-Llorens X., Mertsola J., Ohkawara S., Yoshinaga M., Hansen E. J., McCracken G. H., Jr Role of interleukin 1-beta in meningeal inflammation. Pediatr Infect Dis J. 1989 Dec;8(12):909–910. doi: 10.1097/00006454-198912000-00038. [DOI] [PubMed] [Google Scholar]
  97. Ramilo O., Sáez-Llorens X., Mertsola J., Jafari H., Olsen K. D., Hansen E. J., Yoshinaga M., Ohkawara S., Nariuchi H., McCracken G. H., Jr Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation. J Exp Med. 1990 Aug 1;172(2):497–507. doi: 10.1084/jem.172.2.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Remick D. G., Strieter R. M., Lynch J. P., 3rd, Nguyen D., Eskandari M., Kunkel S. L. In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Kinetics of dexamethasone-induced suppression. Lab Invest. 1989 Jun;60(6):766–771. [PubMed] [Google Scholar]
  99. Rice G. C., Brown P. A., Nelson R. J., Bianco J. A., Singer J. W., Bursten S. Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3857–3861. doi: 10.1073/pnas.91.9.3857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Riesenfeld-Orn I., Wolpe S., Garcia-Bustos J. F., Hoffmann M. K., Tuomanen E. Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components. Infect Immun. 1989 Jul;57(7):1890–1893. doi: 10.1128/iai.57.7.1890-1893.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Roord J. J., Apicella M., Scheld W. M. The induction of meningeal inflammation and blood-brain barrier permeability by Haemophilus influenzae type b peptidoglycan. J Infect Dis. 1994 Jul;170(1):254–256. doi: 10.1093/infdis/170.1.254-a. [DOI] [PubMed] [Google Scholar]
  102. Sampaio E. P., Sarno E. N., Galilly R., Cohn Z. A., Kaplan G. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med. 1991 Mar 1;173(3):699–703. doi: 10.1084/jem.173.3.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Saukkonen K., Sande S., Cioffe C., Wolpe S., Sherry B., Cerami A., Tuomanen E. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med. 1990 Feb 1;171(2):439–448. doi: 10.1084/jem.171.2.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Schaad U. B., Lips U., Gnehm H. E., Blumberg A., Heinzer I., Wedgwood J. Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet. 1993 Aug 21;342(8869):457–461. doi: 10.1016/0140-6736(93)91592-a. [DOI] [PubMed] [Google Scholar]
  105. Schandené L., Vandenbussche P., Crusiaux A., Alègre M. L., Abramowicz D., Dupont E., Content J., Goldman M. Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells. Immunology. 1992 May;76(1):30–34. [PMC free article] [PubMed] [Google Scholar]
  106. Scheinman R. I., Cogswell P. C., Lofquist A. K., Baldwin A. S., Jr Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 1995 Oct 13;270(5234):283–286. doi: 10.1126/science.270.5234.283. [DOI] [PubMed] [Google Scholar]
  107. Scheld W. M., Quagliarello V. J., Wispelwey B. Potential role of host cytokines in Haemophilus influenzae lipopolysaccharide-induced blood-brain barrier permeability. Pediatr Infect Dis J. 1989 Dec;8(12):910–911. doi: 10.1097/00006454-198912000-00039. [DOI] [PubMed] [Google Scholar]
  108. Seitz M., Dewald B., Gerber N., Baggiolini M. Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J Clin Invest. 1991 Feb;87(2):463–469. doi: 10.1172/JCI115018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Seki T., Joh K., Oh-ishi T. Augmented production of interleukin-8 in cerebrospinal fluid in bacterial meningitis. Immunology. 1993 Oct;80(2):333–335. [PMC free article] [PubMed] [Google Scholar]
  110. Selmaj K. W., Raine C. S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol. 1988 Apr;23(4):339–346. doi: 10.1002/ana.410230405. [DOI] [PubMed] [Google Scholar]
  111. Semmler J., Gebert U., Eisenhut T., Moeller J., Schönharting M. M., Alléra A., Endres S. Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunology. 1993 Apr;78(4):520–525. [PMC free article] [PubMed] [Google Scholar]
  112. Sharief M. K., Ciardi M., Thompson E. J. Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-1 beta. J Infect Dis. 1992 Aug;166(2):350–358. doi: 10.1093/infdis/166.2.350. [DOI] [PubMed] [Google Scholar]
  113. Strieter R. M., Remick D. G., Ward P. A., Spengler R. N., Lynch J. P., 3rd, Larrick J., Kunkel S. L. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun. 1988 Sep 30;155(3):1230–1236. doi: 10.1016/s0006-291x(88)81271-3. [DOI] [PubMed] [Google Scholar]
  114. Sullivan G. W., Carper H. T., Novick W. J., Jr, Mandell G. L. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun. 1988 Jul;56(7):1722–1729. doi: 10.1128/iai.56.7.1722-1729.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Suschek C., Rothe H., Fehsel K., Enczmann J., Kolb-Bachofen V. Induction of a macrophage-like nitric oxide synthase in cultured rat aortic endothelial cells. IL-1 beta-mediated induction regulated by tumor necrosis factor-alpha and IFN-gamma. J Immunol. 1993 Sep 15;151(6):3283–3291. [PubMed] [Google Scholar]
  116. Syrogiannopoulos G. A., Hansen E. J., Erwin A. L., Munford R. S., Rutledge J., Reisch J. S., McCracken G. H., Jr Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation. J Infect Dis. 1988 Feb;157(2):237–244. doi: 10.1093/infdis/157.2.237. [DOI] [PubMed] [Google Scholar]
  117. Syrogiannopoulos G. A., Olsen K. D., Reisch J. S., McCracken G. H., Jr Dexamethasone in the treatment of experimental Haemophilus influenzae type b meningitis. J Infect Dis. 1987 Feb;155(2):213–219. doi: 10.1093/infdis/155.2.213. [DOI] [PubMed] [Google Scholar]
  118. Sáez-Llorens X., Jafari H. S., Severien C., Parras F., Olsen K. D., Hansen E. J., Singer I. I., McCracken G. H., Jr Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis. J Clin Invest. 1991 Dec;88(6):2003–2011. doi: 10.1172/JCI115527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Sáez-Llorens X., Ramilo O., Mustafa M. M., Mertsola J., Hansen E. J., McCracken G. H., Jr Modulation of meningeal inflammation by treatment with pentoxifylline. Pediatr Infect Dis J. 1989 Dec;8(12):922–923. doi: 10.1097/00006454-198912000-00046. [DOI] [PubMed] [Google Scholar]
  120. Sáez-Llorens X., Ramilo O., Mustafa M. M., Mertsola J., de Alba C., Hansen E., McCracken G. H., Jr Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis. Antimicrob Agents Chemother. 1990 May;34(5):837–843. doi: 10.1128/aac.34.5.837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Tang T., Frenette P. S., Hynes R. O., Wagner D. D., Mayadas T. N. Cytokine-induced meningitis is dramatically attenuated in mice deficient in endothelial selectins. J Clin Invest. 1996 Jun 1;97(11):2485–2490. doi: 10.1172/JCI118695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Townsend G. C., Scheld W. M. Adjunctive therapy for bacterial meningitis: rationale for use, current status, and prospects for the future. Clin Infect Dis. 1993 Nov;17 (Suppl 2):S537–S549. doi: 10.1093/clinids/17.supplement_2.s537. [DOI] [PubMed] [Google Scholar]
  123. Tsunawaki S., Sporn M., Ding A., Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature. 1988 Jul 21;334(6179):260–262. doi: 10.1038/334260a0. [DOI] [PubMed] [Google Scholar]
  124. Tunkel A. R., Scheld W. M. Pathogenesis and pathophysiology of bacterial meningitis. Clin Microbiol Rev. 1993 Apr;6(2):118–136. doi: 10.1128/cmr.6.2.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Tunkel A. R., Wispelwey B., Quagliarello V. J., Rosser S. W., Lesse A. J., Hansen E. J., Scheld W. M. Pathophysiology of blood-brain barrier alterations during experimental Haemophilus influenzae meningitis. J Infect Dis. 1992 Jun;165 (Suppl 1):S119–S120. doi: 10.1093/infdis/165-supplement_1-s119. [DOI] [PubMed] [Google Scholar]
  126. Tuomanen E. I., Saukkonen K., Sande S., Cioffe C., Wright S. D. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J Exp Med. 1989 Sep 1;170(3):959–969. doi: 10.1084/jem.170.3.959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Tuomanen E., Hengstler B., Rich R., Bray M. A., Zak O., Tomasz A. Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis. J Infect Dis. 1987 May;155(5):985–990. doi: 10.1093/infdis/155.5.985. [DOI] [PubMed] [Google Scholar]
  128. Tuomanen E., Hengstler B., Zak O., Tomasz A. Induction of meningeal inflammation by diverse bacterial cell walls. Eur J Clin Microbiol. 1986 Dec;5(6):682–684. doi: 10.1007/BF02013304. [DOI] [PubMed] [Google Scholar]
  129. Tuomanen E., Liu H., Hengstler B., Zak O., Tomasz A. The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis. 1985 May;151(5):859–868. doi: 10.1093/infdis/151.5.859. [DOI] [PubMed] [Google Scholar]
  130. Tuomanen E., Tomasz A., Hengstler B., Zak O. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J Infect Dis. 1985 Mar;151(3):535–540. doi: 10.1093/infdis/151.3.535. [DOI] [PubMed] [Google Scholar]
  131. Tureen J. H., Täuber M. G., Sande M. A. Effect of hydration status on cerebral blood flow and cerebrospinal fluid lactic acidosis in rabbits with experimental meningitis. J Clin Invest. 1992 Mar;89(3):947–953. doi: 10.1172/JCI115676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Tureen J. H., Täuber M. G., Sande M. A. Effect of indomethacin on the pathophysiology of experimental meningitis in rabbits. J Infect Dis. 1991 Mar;163(3):647–649. doi: 10.1093/infdis/163.3.647. [DOI] [PubMed] [Google Scholar]
  133. Tureen J. Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: role of nitric oxide. J Clin Invest. 1995 Mar;95(3):1086–1091. doi: 10.1172/JCI117755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Täuber M. G., Borschberg U., Sande M. A. Influence of granulocytes on brain edema, intracranial pressure, and cerebrospinal fluid concentrations of lactate and protein in experimental meningitis. J Infect Dis. 1988 Mar;157(3):456–464. doi: 10.1093/infdis/157.3.456. [DOI] [PubMed] [Google Scholar]
  135. Täuber M. G. Brain edema, intracranial pressure and cerebral blood flow in bacterial meningitis. Pediatr Infect Dis J. 1989 Dec;8(12):915–917. doi: 10.1097/00006454-198912000-00042. [DOI] [PubMed] [Google Scholar]
  136. Täuber M. G., Khayam-Bashi H., Sande M. A. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis. 1985 Mar;151(3):528–534. doi: 10.1093/infdis/151.3.528. [DOI] [PubMed] [Google Scholar]
  137. Täuber M. G., Sachdeva M., Kennedy S. L., Loetscher H., Lesslauer W. Toxicity in neuronal cells caused by cerebrospinal fluid from pneumococcal and gram-negative meningitis. J Infect Dis. 1992 Nov;166(5):1045–1050. doi: 10.1093/infdis/166.5.1045. [DOI] [PubMed] [Google Scholar]
  138. Täuber M. G., Shibl A. M., Hackbarth C. J., Larrick J. W., Sande M. A. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. J Infect Dis. 1987 Sep;156(3):456–462. doi: 10.1093/infdis/156.3.456. [DOI] [PubMed] [Google Scholar]
  139. Täuber M. G., Zwahlen A. Animal models for meningitis. Methods Enzymol. 1994;235:93–106. doi: 10.1016/0076-6879(94)35134-1. [DOI] [PubMed] [Google Scholar]
  140. Van Meir E., Ceska M., Effenberger F., Walz A., Grouzmann E., Desbaillets I., Frei K., Fontana A., de Tribolet N. Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res. 1992 Aug 15;52(16):4297–4305. [PubMed] [Google Scholar]
  141. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol. 1990;8:253–278. doi: 10.1146/annurev.iy.08.040190.001345. [DOI] [PubMed] [Google Scholar]
  142. Visser J. J., Scholten R. J., Hoekman K. Nitric oxide synthesis in meningococcal meningitis. Ann Intern Med. 1994 Feb 15;120(4):345–346. doi: 10.7326/0003-4819-120-4-199402150-00023. [DOI] [PubMed] [Google Scholar]
  143. Waage A., Bakke O. Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology. 1988 Feb;63(2):299–302. [PMC free article] [PubMed] [Google Scholar]
  144. Waage A., Halstensen A., Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. 1987 Feb 14;1(8529):355–357. doi: 10.1016/s0140-6736(87)91728-4. [DOI] [PubMed] [Google Scholar]
  145. Waage A., Halstensen A., Shalaby R., Brandtzaeg P., Kierulf P., Espevik T. Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med. 1989 Dec 1;170(6):1859–1867. doi: 10.1084/jem.170.6.1859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Waage A., Sørensen M., Størdal B. Differential effect of oxpentifylline on tumour necrosis factor and interleukin-6 production. Lancet. 1990 Mar 3;335(8688):543–543. doi: 10.1016/0140-6736(90)90779-5. [DOI] [PubMed] [Google Scholar]
  147. Wahl S. M., Hunt D. A., Wakefield L. M., McCartney-Francis N., Wahl L. M., Roberts A. B., Sporn M. B. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A. 1987 Aug;84(16):5788–5792. doi: 10.1073/pnas.84.16.5788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Wahl S. M., McCartney-Francis N., Mergenhagen S. E. Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today. 1989 Aug;10(8):258–261. doi: 10.1016/0167-5699(89)90136-9. [DOI] [PubMed] [Google Scholar]
  149. Wald E. R., Kaplan S. L., Mason E. O., Jr, Sabo D., Ross L., Arditi M., Wiedermann B. L., Barson W., Kim K. S., Yogov R. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group. Pediatrics. 1995 Jan;95(1):21–28. [PubMed] [Google Scholar]
  150. Wang P., Wu P., Siegel M. I., Egan R. W., Billah M. M. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol. 1994 Jul 15;153(2):811–816. [PubMed] [Google Scholar]
  151. Wanidworanun C., Strober W. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol. 1993 Dec 15;151(12):6853–6861. [PubMed] [Google Scholar]
  152. Wispelwey B., Hansen E. J., Lesse A., Scheld W. M. Haemophilus influenzae virulence factors in experimental meningitis. Pediatr Infect Dis J. 1989 Dec;8(12):903–904. doi: 10.1097/00006454-198912000-00035. [DOI] [PubMed] [Google Scholar]
  153. Xie Q., Nathan C. The high-output nitric oxide pathway: role and regulation. J Leukoc Biol. 1994 Nov;56(5):576–582. doi: 10.1002/jlb.56.5.576. [DOI] [PubMed] [Google Scholar]
  154. Zabel P., Wolter D. T., Schönharting M. M., Schade U. F. Oxpentifylline in endotoxaemia. Lancet. 1989 Dec 23;2(8678-8679):1474–1477. doi: 10.1016/s0140-6736(89)92929-2. [DOI] [PubMed] [Google Scholar]
  155. de Waal Malefyt R., Abrams J., Bennett B., Figdor C. G., de Vries J. E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991 Nov 1;174(5):1209–1220. doi: 10.1084/jem.174.5.1209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. van Furth A. M., Seijmonsbergen E. M., Groeneveld P. H., van Furth R., Langermans J. A. Levels of nitric oxide correlate with high levels of tumor necrosis factor alpha in cerebrospinal fluid samples from children with bacterial meningitis. Clin Infect Dis. 1996 May;22(5):876–878. doi: 10.1093/clinids/22.5.876. [DOI] [PubMed] [Google Scholar]
  157. van Furth A. M., Seijmonsbergen E. M., Langermans J. A., Groeneveld P. H., de Bel C. E., van Furth R. High levels of interleukin 10 and tumor necrosis factor alpha in cerebrospinal fluid during the onset of bacterial meningitis. Clin Infect Dis. 1995 Jul;21(1):220–222. doi: 10.1093/clinids/21.1.220. [DOI] [PubMed] [Google Scholar]
  158. van Furth A. M., Seijmonsbergen E. M., Langermans J. A., van der Meide P. H., van Furth R. Effect of xanthine derivates and dexamethasone on Streptococcus pneumoniae-stimulated production of tumor necrosis factor alpha, interleukin-1 beta (IL-1 beta), and IL-10 by human leukocytes. Clin Diagn Lab Immunol. 1995 Nov;2(6):689–692. doi: 10.1128/cdli.2.6.689-692.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. van Furth A. M., Steenwijk T. M., Langermans J. A., van Furth R. In vitro effect of dexamethasone, pentoxifylline, and anti-endotoxin monoclonal antibody on the release of proinflammatory mediators by human leukocytes stimulated with Haemophilus influenzae type B. Pediatr Res. 1994 Jun;35(6):725–728. doi: 10.1203/00006450-199406000-00020. [DOI] [PubMed] [Google Scholar]
  160. van der Poll T., Jansen J., Levi M., ten Cate H., ten Cate J. W., van Deventer S. J. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med. 1994 Nov 1;180(5):1985–1988. doi: 10.1084/jem.180.5.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES